Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Becton Dickinson (BDX) Currently 25% Undervalued And Given Strong Buy-Rating By Portfolio Manager
Becton Dickinson (BDX) Currently 25% Undervalued And Given Strong Buy-Rating By Portfolio Manager
Becton Dickinson (BDX) Currently 25% Undervalued And Given Strong Buy-Rating By Portfolio Manager
Submitted by
admin
on May 8, 2010 - 9:13am
Source:
Yahoo/Wall Street Transcript
News Tags:
Becton Dickinson
Headline:
Becton Dickinson (BDX) Currently 25% Undervalued And Given Strong Buy-Rating By Portfolio Manager
Do Not Allow Advertisers to Use My Personal information
